PO.ET01.04 · 实验与分子治疗

An analysis of orthosteric missense kinase mutations among a clinical sequencing cohort of over 90,000 cancer patients

编号 319 展板 4 时间 4/19 02:00–05:00 区域 Section 14 主讲 Jessica White, BA;MS
分会场 Kinase and Signaling Pathway Dependencies Driving Cancer Therapeutic Response
该海报暂无可访问的完整资料 AACR 官方页面 ↗

作者与单位

Jessica B. White1, John D. Chodera2, Wesley Tansey3

1Tri-Institutional PhD Program in Computational Biology and Medicine (Memorial Sloan Kettering Cancer Center), New York, NY,2Sloan Kettering Institute, Computational & Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY,3Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

摘要 Abstract

Being among the most well-studied family in the human proteome, the approximately 500 kinases that constitute the human kinome possess ample sequence, structural, and functional annotations within both pan-proteome and kinase-specific resources. Analyzing mutations in homologous residues, particularly in the orthosteric binding pocket, can provide insights into recurrent mechanisms of pathogenicity and drug resistance. However, harmonizing these resources poses a non-trivial task: identifier disambiguation, mapping between disparate sequence representations, and even concordance between resources as to what constitutes a kinase enzyme all pose significant challenges. Here, we describe the creation of a Python package to reliably and reproducibly curate and harmonize kinase sequences. We use this toolkit to interrogate missense mutations within the orthosteric kinase binding site from Memorial Sloan Kettering Cancer Center's (MSKCC) clinical sequencing cohort. We mapped the 85-residue binding site from the Kinase-Ligand Interaction Fingerprints and Structures (KLIFS) database to the canonical UniProt sequence for a superset of kinases from various resources. Among the 126,930 samples from the 93,249 patients in MSKCC's clinical sequencing cohort as of mid-November 2025, we identified 99 kinase genes assessed for somatic mutations. Within the 87 kinases that mapped to the canonical UniProt sequence, we detected 6,198 unique single amino acid substitutions in the ATP-binding pocket in at least one sample in 11,071 (11.9%) of patients. KLIFS regions with significantly higher percentages of kinases containing one or more such alterations included the gatekeeper (median: 65.9%), linker (65.3%), catalytic loop (61.8%), activation loop/xDFG motif (61.2%), and glycine-rich loop (56.5%), while beta-sheet regions (47.1%) had significantly lower percentages. Kinase families that possessed a significantly higher percentages of KLIFS residues containing one or more such alterations included tyrosine kinase (61.9%) and STE (59.5%), while tyrosine kinase-like (54.8%), AGC (51.8%), calcium/calmodulin-dependent protein kinase (51.2%), and atypical kinases (44.0%) had significantly lower percentages. Since our toolkit harmonizes sequences across the human kinome, it provides a multiple sequence alignment to evaluate species-level protein family conservation. We identified highly conserved, frequently mutated residues in the glycine residues of the glycine-rich loop, the arginine of the HRD motif, and the aspartic acid of the xDFG motif. Our analysis provides a unique pan-cancer assessment of missense mutations across the human kinome, suggesting shared functional mechanisms of pathogenicity for further characterization. Our tools can be used to interrogate missense kinase mutations in any cBioPortal cohort in a similar manner.
利益披露 Disclosure
J. B. White, SpringWorks Therapeutics Stock, Stock Option, ). J. D. Chodera, OpenEye Scientific Software Other, Scientific Advisory Board. Achira Inc. Employment, Stock, Stock Option. W. Tansey, None.

在会议检索中打开